Latest News
Agetech World explores the latest investment developments in healthy ageing and longevity. US$10m to develop cell reset therapeutics for longevity Biotech company Junevity has raised US$10m in seed funding to accelerate its Junevity RESET platform. The platform is based on exclusively licensed research by co-founder Dr. Janine Sengstack at the University of California at San [...]
The rise in human life expectancy has slowed down across Europe since 2011, according to research from the University of East Anglia and partners. A new study reveals that the food we eat, physical inactivity and obesity are largely to blame, as well as the Covid pandemic. Of all the countries studied, England experienced the [...]
Research has demonstrated that severe early-life adversity is linked to measurable markers of accelerated brain ageing and can amplify neurodegenerative processes later in life. Stressful or traumatic experiences in childhood have been shown to negatively impact an individual’s health as an adult. Those affected face an increased risk of illness and often suffer from depression, [...]
Biotechnology company Junevity has raised $10m in funding to advance its RESET platform, which uses large-scale human data and AI to identify genes – or transcription factors – that can regulate cell damage, and to develop its first therapeutic candidates in Type 2 diabetes, obesity and frailty. Diseases like obesity, diabetes, frailty, neurodegeneration and many [...]
By Lily Vittayarukskul, co-founder and CEO, Waterlily. As lifespans extend and healthcare needs evolve, long-term care (LTC) planning stands as one of the final frontiers in retirement strategy. It continues to challenge retirement planning for both families and financial advisors and outdated tools fall short in preparing families for what's ahead. Traditional methods have never [...]
Two Alzheimer's drugs that have been approved in the last two years by the US Food and Drug Administration (FDA) have been shown to extend independent living by months. The drugs - lecanemab and donanemab - have been shown to slow the progression of Alzheimer's disease in clinical studies. However, according to physicians who care [...]
Healthcare providers saw an increase in vaccine uptake from older adults after they were provided with a decision making tool that provided vaccine information, a study has revealed. Currently, only 15 per cent of Americans ages 50 and older and 25 per cent of Americans ages 65 and older are up to date on all [...]
In an unusual case, a 23-year-old man with severe bone loss and spinal fractures has been found to have systemic mastocytosis (SM) - a rare blood disorder that causes certain immune cells, called mast cells, to build up in different parts of the body. The case highlights how SM can go undiagnosed, and may be [...]
A simple scoring system could revolutionise how doctors prevent heart attacks and strokes by identifying patients most likely to benefit from preventive medications, according to a new study. The breakthrough test, called the TRIPLE Score, measures specific proteins on blood platelets along with the patient's age to help doctors make more informed decisions about prescribing [...]
A minimally invasive Targeted Thermal Therapy (Triple T) that has the potential to transform medical management of a common, but commonly overlooked, cause of high blood pressure has been developed, offering new hope for hypertension treatment. This breakthrough could, after further testing, help millions of people worldwide who currently go undiagnosed and untreated. For the [...]
